Oxford Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Oxford Asset Management’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-162,047	Closed	-$3.43M	–	2005
2017 Q3	$3.43M	Sell	162,047 -102,678	-39%	-$1.96M	0.07%	355
2017 Q2	$4.26M	Sell	264,725 -116,237	-31%	-$1.72M	0.08%	252
2017 Q1	$4.82M	Buy	380,962 +271,450	+248%	+$3.28M	0.12%	157
2016 Q4	$1.45M	Buy	109,512 +28,172	+35%	+$482K	0.05%	400
2016 Q3	$1.93M	Buy	81,340 +64,451	+382%	+$1.73M	0.06%	413
2016 Q2	$487K	Buy	+16,889	New	+$550K	0.02%	588
2014 Q4	–	Sell	-81,142	Closed	-$1.95M	–	829
2014 Q3	$1.95M	Buy	81,142 +65,017	+403%	+$1.67M	0.04%	373
2014 Q2	$484K	Sell	16,125 -50,824	-76%	-$1.37M	0.02%	572
2014 Q1	$1.77M	Sell	66,949 -83,335	-55%	-$2.08M	0.05%	386
2013 Q4	$3.78M	Sell	150,284 -72,784	-33%	-$1.62M	0.09%	289
2013 Q3	$4.58M	Sell	223,068 -13,964	-6%	-$288K	0.1%	267
2013 Q2	$4.73M	Buy	+237,032	New	+$4.21M	0.13%	253

Other funds holding IPXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Oxford Asset Management's IPXL Position: Q4 2017 in Review

Oxford Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q4 2017, closing a stake of 162,047 shares — an estimated $3.43M sold.

Oxford Asset Management first reported a position in IPXL in Q2 2013 and held it in 12 quarters. The position peaked at $4.82M in Q1 2017. 200 funds tracked by Wall St. Rank hold IPXL as of Q4 2017.

Oxford Asset Management reported no remaining Impax Laboratories, Inc. position as of Q4 2017 after selling out during the quarter.
Oxford Asset Management sold 162,047 Impax Laboratories, Inc. shares in Q4 2017, an estimated $3.43M.
Oxford Asset Management first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 12 quarters.
Oxford Asset Management's Impax Laboratories, Inc. position peaked at $4.82M in Q1 2017.
200 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2017.

Based on Oxford Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.